Search

Your search keyword '"Valeria Valim"' showing total 225 results

Search Constraints

Start Over You searched for: Author "Valeria Valim" Remove constraint Author: "Valeria Valim"
225 results on '"Valeria Valim"'

Search Results

1. Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer

2. Recommendations on cutaneous and hematological manifestations of Sjögren’s disease by the Brazilian Society of Rheumatology

Catalog

Books, media, physical & digital resources

3. Prevalence of spondyloarthritis in inflammatory bowel disease according ASAS and ultrassonography and its correlation with plasma calprotectin

4. Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER Cohort

5. Beliefs and attitudes about chronic pain among public health professionals: cross-sectional study

6. Recommendations for evaluation and diagnosis of extra-glandular manifestations of primary Sjögren syndrome: results of an epidemiologic systematic review/meta-analysis and a consensus guideline from the Brazilian society of rheumatology (hepatic, gastrointestinal and pancreatic)

7. VI Brazilian consensus guidelines for detection of anti-cell autoantibodies on HEp-2 cells

8. Recommendations for evaluation and diagnosis of extra-glandular manifestations of primary sjogren syndrome: results of an epidemiologic systematic review/meta-analysis and a consensus guideline from the Brazilian Society of Rheumatology (articular, pulmonary and renal)

9. Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil

10. 2021 recommendations of the Brazilian Society of Rheumatology for the gynecological and obstetric care of patients with Sjogren’s syndrome

11. Pain and fatigue are predictors of quality of life in primary Sjögren’s syndrome

12. Correction to: 2021 recommendations of the Brazilian Society of Rheumatology for the gynecological and obstetric care of patients with Sjogren’s syndrome

13. Recommendations from the Brazilian society of rheumatology for the diagnosis of Sjögren’s syndrome (Part I): glandular manifestations (systematic review)

14. Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases

15. Understanding Fatigue in Sjögren’s Syndrome: Outcome Measures, Biomarkers and Possible Interventions

16. IV Consenso Brasileiro para pesquisa de autoanticorpos em células HEp-2

17. Artrite enteropática no Brasil: dados do registro brasileiro de espondiloartrites

18. Baixa prevalência das manifestações extra-articulares renais, cardíacas, pulmonares e neurológicas nas espondiloartrites: análise do Registro Brasileiro de Espondiloartrites Low prevalence of renal, cardiac, pulmonary, and neurological extra-articular clinical manifestations in spondyloarthritis: analysis of the Brazilian Registry of Spondyloarthritis

19. Errata de 'Artrite enteropática no Brasil: dados do Registro Brasileiro de Espondiloartrites'

20. AVALIAÇÃO DA EFETIVIDADE, IMUNOGENICIDADE E SEGURANÇA DA SEGUNDA DOSE DE REFORÇO (QUARTA DOSE) DA VACINA CONTRA A COVID-19 EM IDOSOS: ESTUDO REFORÇA MAIS (PLUS BOOSTER)

21. NÃO INFERIORIDADE DA RESPOSTA IMUNE EM CRIANÇAS DE 3 E 4 ANOS APÓS A VACINA INATIVADA (CORONAVAC) COMPARADO A CRIANÇAS MAIORES E ADULTOS

22. IMUNOGENICIDADE E SEGURANÇA DA VACINA INATIVADA (CORONAVAC) COMPARADA À VACINA BNT162B2 (PFIZER) CONTRA SARS-COV-2 EM CRIANÇAS E ADOLESCENTES (PROJETO CURUMIM)

23. PROJETO CURUMIM E HESITAÇÃO VACINAL COM VACINAS CONTRA COVID-19 EM UMA COORTE DE CRIANÇAS E ADOLESCENTES

24. Participating as a research team during the COVID-19 pandemic benefits mental health of undergraduate medical students in Brazil

25. THE IMPACT OF TIMELY ACCESS TO AN ASSISTED THERAPY CENTER

26. RELAPSING POLYCHONDRITIS AFTER PLASTIC SURGERY

27. REATOGENICITY AFTER PLANNED VACCINATION WITH CHADOX1, SINOVAC AND BNT162B2 VACCINES IN PATIENTS WITH AUTOIMMUNE DISEASE: DATA FROM THE SAFER STUDY

28. Safety assessment of BNT162b2, SinoVac and ChAdOx1 vaccines in Systemic Lupus Erythematosus patients in Brazil- SAFER Study

29. TETRAPARESIS IN A PATIENT WITH JUVENILE IDIOPATHIC ARTHRITIS

30. Recurrent polychondritis with ophthalmologic involvement

31. NEUROLOGICAL INVOLVEMENT IN BEHÇET’S DISEASE

32. PHYSICAL ACTIVITY LEVEL IN PATIENTS WITH PRIMARY SJÖGREN'S SYNDROME

33. Prevalência de lesão periapical radiolúcida nos pacientes com síndrome de Sjögren primária

34. CCL3, CCL5, IL-15, IL-1Ra and VEGF compose a reliable algorithm to discriminate classes of adverse events following 17DD-YF primary vaccination according to cause-specific definitions

35. Brazilian version of the 'Primary Sjögren’s Syndrome - Quality of Life questionnaire (PSS-QoL)': translation, cross-cultural adaptation and validation

36. Safety and efficacy of SARS-CoV-2 vaccination in 1237 patients with primary Sjögren syndrome

37. Hydroxychloroquine is associated with lower seroconversion upon 17DD-Yellow fever primovaccination in patients with primary Sjögren’s syndrome

38. Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjogren's syndrome

39. Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil

40. Parotid gland swelling in primary Sjögren's syndrome: activity and other sialadenosis causes

41. Juvenile Sjogren's Syndrome

42. Tendência temporal de prescrição de terapias biológicas para artrite reumatoide

43. Managing fatigue in patients with primary Sjögren’s syndrome: challenges and solutions

44. Health-related quality of life and costs in Sjögren’s syndrome

45. Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort

46. Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination

47. Hydroxychloroquine Impairs Primary Humoral Response after Yellow Fever Vaccination in Primary Sjögren’s Syndrome

48. BRAZILIAN VERSION OF THE 'PRIMARY SJÖGREN SYNDROME - QUALITY OF LIFE QUESTIONNAIRE (PSS-QOL)

49. PERSISTENT LYMPHADENOPATHY IN LUPUS PATIENT ASSOCIATED WITH CASTLEMAN'S DISEASE: A CASE REPORT

50. EPIDEMIOLOGICAL, CLINICAL AND LABORATORY ANALYSIS OF PATIENTS WITH TAKAYASU ARTERITIS AT HOSPITAL UNIVERSITÁRIO CASSIANO ANTÔNIO DE MORAES